Oracle: The Spending Boom Continues

Oracle posted strong Q4 results, with cloud revenue up 46%, but shares fell sharply as investors focused on surging capital spending. The company plans up to $95 billion in gross capex in FY2027, with net debt and equity issuance expected to rise, creating dilution and leverage concerns. Even so, sales are projected to grow nearly 30% with adjusted EPS around $8, implying support for low-20s earnings multiples.

Analysis

The market is not punishing growth; it is re-pricing the quality of growth. Oracle’s capex step-up changes the equity story from software multiple expansion to infrastructure-financing optionality, which means a larger share of future value accrues to lenders, equipment vendors, and hyperscale-adjacent suppliers before it reaches common equity. That creates a near-term burden on free cash flow and balance-sheet flexibility even if top-line momentum remains intact.

The second-order winner is likely the AI infrastructure ecosystem outside Oracle’s equity. If Oracle is forced to fund a multi-year buildout with more debt and possible issuance, suppliers with hard-to-replicate bottlenecks can keep pricing power while avoiding dilution risk; the economic upside shifts toward the picks-and-shovels layer rather than the operator. Competitors with cleaner balance sheets can also use this window to win enterprise deals by emphasizing capex efficiency and faster payback, especially where customers compare total cost of ownership rather than raw model performance.

The key risk is time mismatch: revenue compounding can stay strong for several quarters while the equity de-rates immediately on funding concerns. What can reverse the trend is evidence that incremental capex is translating into materially higher contracted backlog, better utilization, or earlier cash conversion than the market expects; absent that, the stock may remain trapped between earnings growth and balance-sheet skepticism for months. The contrarian view is that investors may be overfocusing on gross capex and underappreciating that in this phase of the AI buildout, scale itself can become a moat if Oracle locks in scarce capacity and long-dated commitments before rivals do.

Key Decisions for Investors

• Avoid chasing ORCL on the first rebound; wait 2-6 weeks for post-earnings revision pressure to reset expectations, then consider a tactical long only if backlog disclosures or guidance imply capex payback is accelerating.
• Pair trade: long a cleaner AI infrastructure beneficiary with lower funding risk against ORCL for 3-6 months; the relative trade captures the market’s preference for growth without dilution over growth financed by balance-sheet expansion.
• Buy ORCL downside protection via put spreads into any strength over the next 1-2 months; the risk/reward favors hedging because multiple compression can occur faster than fundamental revisions.
• If ORCL sells off another 8-12% and management reiterates demand visibility, consider a small contrarian long for a 6-12 month horizon, but size it as a funding-risk trade, not a pure growth trade.